Blood Transfusion Strategies in Patients Undergoing Extracorporeal Membrane Oxygenation
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Extracorporeal membrane oxygenation (ECMO) is frequently associated with bleeding and coagulopathy complications, which may lead to the need for transfusion of multiple blood products. However, blood transfusions are known to increase morbidity and mortality, as well as hospital cost, in critically ill patients. In current practice, patients on ECMO receive a transfusion, on average, of 1-5 packed red blood cells (RBCs)/day, with platelet transfusion accounting for the largest portion of transfusion volume. Generally, adult patients require more transfusions than neonates or children, and patients receiving venovenous ECMO for respiratory failure tend to need smaller transfusion volumes compared to those receiving venoarterial ECMO for cardiac failure. Observation studies have reported that a higher transfusion volume was associated with increased mortality. To date, the evidence for transfusion in patients undergoing ECMO is limited; most knowledge on transfusion strategies was extrapolated from studies in critically ill patients. However, current data support a restrictive blood transfusion strategy for ECMO patients, and a low transfusion trigger seems to be safe and reasonable.
Abstract
Extracorporeal membrane oxygenation (ECMO) is frequently associated with bleeding and coagulopathy complications, which may lead to the need for transfusion of multiple blood products. However, blood transfusions are known to increase morbidity and mortality, as well as hospital cost, in critically ill patients. In current practice, patients on ECMO receive a transfusion, on average, of 1-5 packed red blood cells (RBCs)/day, with platelet transfusion accounting for the largest portion of transfusion volume. Generally, adult patients require more transfusions than neonates or children, and patients receiving venovenous ECMO for respiratory failure tend to need smaller transfusion volumes compared to those receiving venoarterial ECMO for cardiac failure. Observation studies have reported that a higher transfusion volume was associated with increased mortality. To date, the evidence for transfusion in patients undergoing ECMO is limited; most knowledge on transfusion strategies was extrapolated from studies in critically ill patients. However, current data support a restrictive blood transfusion strategy for ECMO patients, and a low transfusion trigger seems to be safe and reasonable.
참고문헌 (34)
- "ELSO guidelines" (2016)[URL]
- Holst LB., "Benefits and harms of red blood cell transfusions in patients with septic shock in the intensive care unit", Dan Med J, 63, pp.B5209~ (2016)
- Gilliss BM, "Reducing noninfectious risks of blood transfusion", Anesthesiology, 115, pp.635~649 (2011)
- Hébert PC, "A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group", N Engl J Med, 340, pp.409~417 (1999)
- Holst LB, "Lower versus higher hemoglobin threshold for transfusion in septic shock", N Engl J Med, 371, pp.1381~1391 (2014)
- Roberson RS, "Impact of red blood cell transfusion on global and regional measures of oxygenation", Mt Sinai J Med, 79, pp.66~74 (2012)
- Kiefel V., "Reactions induced by platelet transfusions", Transfus Med Hemother, 35, pp.354~358 (2008)
- Lelubre C, "Red blood cell transfusion in the critically ill patient", Ann Intensive Care, 1, pp.43~ (2011)
- Tinmouth A, "Canadian Critical Care Trials Group. Clinical consequences of red cell storage in the critically ill", Transfusion, 46, pp.2014~2027 (2006)
- Koch CG, "Duration of red-cell storage and complications after cardiac surgery", Engl J Med, 358, pp.1229~1239 (2008)
- Schmidt M, "Blood oxygenation and decarboxylation determinants during venovenous ECMO for respiratory failure in adults", Intensive Care Med, 39, pp.838~846 (2013)
- Marik PE, "Liberal or restrictive transfusion after cardiac surgery", N Engl J Med, 373, pp.190~191 (2015)
- Carson JL, "Liberal or restrictive transfusion in high-risk patients after hip surgery", N Engl J Med, 365, pp.2453~2462 (2011)
- Murphy GJ, "TITRe2 Investigators : Liberal or restrictive transfusion after cardiac surgery", N Engl J Med, 372, pp.997~1008 (2015)
- Holst LB, "Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis", BMJ, 350, pp.h1354~ (2015)
- Joshi V, "The need for thoracic surgery in adult patients receiving extracorporeal membrane oxygenation : a 16-year experience", Perfusion, 28, pp.328~332 (2013)
- Tolksdorf B, "Autotransfusion during extracorporeal membrane oxygenation", Int J Artif Organs, 23, pp.840~844 (2000)
- Arnold P, "Coagulation factor activity during neonatal extra-corporeal membrane oxygenation", Intensive Care Med, 27, pp.1395~1400 (2001)
- Butch SH, "Blood utilization in adult patients undergoing extracorporeal membrane oxygenated therapy", Transfusion, 36, pp.61~63 (1996)
- McCoy-Pardington D, "Blood use during extracorporeal membrane oxygenation", Transfusion, 30, pp.307~309 (1990)
- Morris AH, "Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome", Am J Respir Crit Care Med, 149(2 Pt 1), pp.295~305 (1994)
- Peek GJ, "Extracorporeal membrane oxygenation for adult respiratory failure", Chest, 112, pp.759~764 (1997)
- Ang AL, "Blood transfusion requirements and independent predictors of increased transfusion requirements among adult patients on extracorporeal membrane oxygenation--a single centre experience", Vox Sang, 96, pp.34~43 (2009)
- Chevuru SC, "Florida Collaborative Neonatology Research Group: multicenter analysis of platelet transfusion usage among neonates on extracorporeal membrane oxygenation", Pediatrics, 109, pp.e89~ (2002)
- Henríquez-Henríquez M, "Blood component usage during extracorporeal membrane oxygenation : experience in 98 patients at a Latin-American tertiary hospital", Int J Artif Organs, 37, pp.233~240 (2014)
- Omar HR, "Plasma free hemoglobin is an independent predictor of mortality among patients on extracorporeal membrane oxygenation support", PLoS One, 10, pp.e0124034~ (2015)
- Australia, New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators, "Extracorporeal membrane oxygenation for 2009influenza A(H1N1)acute respiratory distress syndrome", JAMA, 302, pp.1888~1895 (2009)
- Patroniti N, "The Italian ECMO network experience during the 2009 influenza A(H1N1)pandemic : preparation for severe respiratory emergency outbreaks", Intensive Care Med, 37, pp.1447~1457 (2011)
- Smith A, "Red blood cell transfusion volume and mortality among patients receiving extracorporeal membrane oxygenation", Perfusion, 28, pp.54~60 (2013)
- Agerstrand CL, "Blood conservation in extracorporeal membrane oxygenation for acute respiratory distress syndrome", Ann Thorac Surg, 99, pp.590~595 (2015)
- Voelker MT, "Restrictive transfusion practice during extracorporeal membrane oxygenation therapy for severe acute respiratory distress syndrome", Artif Organs, 39, pp.374~378 (2015)
- National Heart Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, "Comparison of two fluid-management strategies in acute lung injury", N Engl J Med, 354, pp.2564~2575 (2006)
- Brodie D, "Extracorporeal membrane oxygenation for ARDS in adults", N Engl J Med, 365, pp.1905~1914 (2011)
- Rosenberg EM, "A program to limit donor exposures to neonates undergoing extracorporeal membrane oxygenation", Pediatrics, 94, pp.341~346 (1994)